Octave® Bioscience, Inc. Announces Chairman of the Board, CEO Transition in Preparation for Accelerated Commercial Growth and Increased Patient Access for its Precision Care Solution

MENLO PARK, Calif.–(BUSINESS WIRE)–Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, is pleased to announce that as part of its long-term succession plan, entrepreneur and Octave founder, William Hagstrom, will transition into the role of Chairman…
Click here to view original post